barbara burtness, md on whether the checkmate-141 study will accelerate the use of pd-l1 testing
Published 8 years ago • 41 plays • Length 0:39
Download video MP4
Download video MP3
Similar videos
-
1:41
barbara burtness, md, considers whether h&n patients should be routinely tested for pd-l1
-
1:40
dr. burtness on the use of biomarkers in metastatic hnscc
-
2:57
barbara burtness, md, discusses immunotherapies and treatment of head and neck cancers
-
0:35
barbara burtness, md talks about new patient treatment insights based on the keynote-055 study
-
0:27
barbara burtness, md on the keynote-055 study in scchn patients
-
1:03
laura chow, md interprets the overall survival benefit with opdivo in the checkmate-141 study
-
1:32
barbara burtness, md, shares her thoughts on the results of the lux head and neck 2 study
-
0:53
barbara burtness, md on evidence for incorporating checkpoint inhibitors into treatment
-
14:42
adrenal gland tumors: stefan grebe, m.d., ph.d., and irina bancos, m.d.
-
9:49
patient selection for eribulin in breast cancer
-
3:05
paired tumor biopsies in clinical trials
-
1:37
dr. barbara burtness on the psychology of talking to patients about enrolling in clinical trials
-
4:46
secombit: sequencing of targeted agents/immunomodulatory abs in metastatic brafv600-mutated melanoma
-
1:36
dr. burtness on evolution of molecular testing in head and neck cancer
-
38:23
clinical trials
-
3:16
researcher comment: the blasst-1 trial | shilpa gupta
-
1:58
dr. vokes on nivolumab, pembrolizumab approvals in head and neck cancer
-
17:08
three-year update from the checkmate 227 clinical trial for advanced nsclc
-
4:24
brain: metastatic carcinoma
-
2:29
dr. spigel on checkmate 017- phase iii trial for nivolumab - sarah cannon
-
6:07
interpreting the results of checkmate-227 in nsclc
-
3:26
breath biopsy™ – a non-invasive tool for the early detection of disease and cancer
Clip.africa.com - Privacy-policy